Vbi Vaccines

Commercial‑stage biotech VBI Vaccines, based in Cambridge, develops HBV and CMV vaccines and oncology immunotherapies (VBI‑1901 glioblastoma, VBI‑2601 HBV) with strong pipeline and strategic partnerships.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 131
HQ: Cambridge

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
VBIV	Vbi Vaccines	EQUITY	NCM	USD	CA91822J1030	Review	📈